Literature DB >> 7283322

Mydriatic effect of phenylephrine 10% (aq) vs phenylephrine 2.5% (aq).

R W Neuhaus, R S Hepler.   

Abstract

Pupil dilation from commercially available phenylephrine compounds was studied in a group of 11 subjects. Phenylephrine 10% (aq) did not produce significantly more mydriasis than phenylephrine 2.5% (aq) in the general population (P less than 0.05). This suggests that phenylephrine 2.5% can be used instead of phenylephrine 10% for diagnostic dilation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7283322

Source DB:  PubMed          Journal:  Ann Ophthalmol        ISSN: 0003-4886


  3 in total

Review 1.  Management of mydriasis and pain in cataract and intraocular lens surgery: review of current medications and future directions.

Authors:  Seanna R Grob; Luis A Gonzalez-Gonzalez; Mary K Daly
Journal:  Clin Ophthalmol       Date:  2014-07-03

2.  Safety of tropicamide and phenylephrine in pupillary mydriasis for cataract surgery.

Authors:  Sikander A K Lodhi; Manjula V Ramsali; Dilip K Kulkarni; P Surender; Srinivasa Murty
Journal:  Saudi J Ophthalmol       Date:  2022-02-18

3.  Revisiting the impact of phenylephrine hydrochloride on static and dynamic accommodation.

Authors:  Samrat Sarkar; Ali Mohammed Hasnat; Shrikant R Bharadwaj
Journal:  Indian J Ophthalmol       Date:  2012 Nov-Dec       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.